These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20850464)

  • 1. Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis.
    Scullion GA; Kendall DA; Marsden CA; Sunter D; Pardon MC
    Neuropharmacology; 2011; 60(2-3):223-34. PubMed ID: 20850464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice.
    Minkeviciene R; Ihalainen J; Malm T; Matilainen O; Keksa-Goldsteine V; Goldsteins G; Iivonen H; Leguit N; Glennon J; Koistinaho J; Banerjee P; Tanila H
    J Neurochem; 2008 May; 105(3):584-94. PubMed ID: 18042177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
    Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits.
    Jardanhazi-Kurutz D; Kummer MP; Terwel D; Vogel K; Dyrks T; Thiele A; Heneka MT
    Neurochem Int; 2010 Nov; 57(4):375-82. PubMed ID: 20144675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
    Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
    Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.
    Duffy AM; Hölscher C
    Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prazosin, an α(1)-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease.
    Katsouri L; Vizcaychipi MP; McArthur S; Harrison I; Suárez-Calvet M; Lleo A; Lloyd DG; Ma D; Sastre M
    Neurobiol Aging; 2013 Apr; 34(4):1105-15. PubMed ID: 23063647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent disruption in hippocampal θ oscillation in amyloid-β overproducing transgenic mice.
    Scott L; Feng J; Kiss T; Needle E; Atchison K; Kawabe TT; Milici AJ; Hajós-Korcsok E; Riddell D; Hajós M
    Neurobiol Aging; 2012 Jul; 33(7):1481.e13-23. PubMed ID: 22227005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent increase in lysosome-associated membrane protein 1 and early-onset behavioral deficits in APPSL transgenic mouse model of Alzheimer's disease.
    Hashimoto T; Ogino K; Shin RW; Kitamoto T; Kikuchi T; Shimizu N
    Neurosci Lett; 2010 Jan; 469(2):273-7. PubMed ID: 20025930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque load in mice bearing amyloid precursor protein and presenilin-1 mutant transgenes.
    Pugh PL; Vidgeon-Hart MP; Ashmeade T; Culbert AA; Seymour Z; Perren MJ; Joyce F; Bate ST; Babin A; Virley DJ; Richardson JC; Upton N; Sunter D
    J Neuroinflammation; 2007 Feb; 4():8. PubMed ID: 17324270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1δE9-deleted transgenic mice model of ß-amyloidosis.
    Volianskis A; Køstner R; Mølgaard M; Hass S; Jensen MS
    Neurobiol Aging; 2010 Jul; 31(7):1173-87. PubMed ID: 18790549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
    Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term social isolation exacerbates the impairment of spatial working memory in APP/PS1 transgenic mice.
    Huang HJ; Liang KC; Ke HC; Chang YY; Hsieh-Li HM
    Brain Res; 2011 Jan; 1371():150-60. PubMed ID: 21114967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of GD3 synthase improves memory and reduces amyloid-beta plaque load in transgenic mice.
    Bernardo A; Harrison FE; McCord M; Zhao J; Bruchey A; Davies SS; Jackson Roberts L; Mathews PM; Matsuoka Y; Ariga T; Yu RK; Thompson R; McDonald MP
    Neurobiol Aging; 2009 Nov; 30(11):1777-91. PubMed ID: 18258340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enoxaparin treatment administered at both early and late stages of amyloid β deposition improves cognition of APPswe/PS1dE9 mice with differential effects on brain Aβ levels.
    Timmer NM; van Dijk L; van der Zee CE; Kiliaan A; de Waal RM; Verbeek MM
    Neurobiol Dis; 2010 Oct; 40(1):340-7. PubMed ID: 20600909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The occurrence of a deficit in contextual fear extinction in adult amyloid-over-expressing TASTPM mice is independent of the strength of conditioning but can be prevented by mild novel cage stress.
    Rattray I; Scullion GA; Soulby A; Kendall DA; Pardon MC
    Behav Brain Res; 2009 Jun; 200(1):83-90. PubMed ID: 19162086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
    Heikkinen T; Kalesnykas G; Rissanen A; Tapiola T; Iivonen S; Wang J; Chaudhuri J; Tanila H; Miettinen R; Puoliväli J
    Exp Neurol; 2004 May; 187(1):105-17. PubMed ID: 15081593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
    Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
    Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.